Neuroimaging & Brain MeasuresPsilocybinMescalineLSD

Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity

This animal study assesses the effects of tryptamine and phenethylamine psychedelics (psilocin, LSD, mescaline and dimethoxybromoamphetamine (DOB)) using EEG in freely moving rats. The researchers found that all psychedelic's caused a global decrease in EEG activity. The overall results were almost identical to the effects from human EEG studies, proving that the method has robust translational validity.

Authors

  • Tomáš Páleníček
  • František Tylš

Published

Translational Psychiatry
individual Study

Abstract

Serotonergic psychedelics are recently gaining a lot of attention as a potential treatment of several neuropsychiatric disorders. Broadband desynchronization of EEG activity and disconnection in humans have been repeatedly shown; however, translational data from animals are completely lacking. Therefore, the main aim of our study was to assess the effects of tryptamine and phenethylamine psychedelics (psilocin 4 mg/kg, LSD 0.2 mg/kg, mescaline 100 mg/kg, and DOB 5 mg/kg) on EEG in freely moving rats. A system consisting of 14 cortical EEG electrodes, co-registration of behavioral activity of animals with subsequent analysis only in segments corresponding to behavioral inactivity (resting-state-like EEG) was used in order to reach a high level of translational validity. Analyses of the mean power, topographic brain-mapping, and functional connectivity revealed that all of the psychedelics irrespective of the structural family induced overall and time-dependent global decrease/desynchronization of EEG activity and disconnection within 1-40 Hz. Major changes in activity were localized on the large areas of the frontal and sensorimotor cortex showing some subtle spatial patterns characterizing each substance. A rebound of occipital theta (4-8 Hz) activity was detected at later stages after treatment with mescaline and LSD. Connectivity analyses showed an overall decrease in global connectivity for both the components of cross-spectral and phase-lagged coherence. Since our results show almost identical effects to those known from human EEG/MEG studies, we conclude that our method has robust translational validity.

Available with Blossom Pro

Research Summary of 'Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity'

Introduction

Serotonergic psychedelics—principally tryptamine derivatives (for example LSD, psilocybin/psilocin, DMT) and phenethylamine derivatives (for example mescaline, DOB)—produce similar subjective effects in humans largely via 5-HT2A receptor agonism. Human neuroimaging and electrophysiology studies have repeatedly reported a broadband decrease in spectral power (most pronounced in the alpha band) and reductions in functional connectivity during psychedelic states, but comparable whole‑brain EEG data from awake, freely moving laboratory animals are lacking. Earlier animal EEG work was often done under anaesthesia or immobilisation, and recent preclinical recordings have mostly focused on local field potentials rather than multichannel cortical surface signals that approximate human resting‑state EEG. Vejmola and colleagues set out to characterise and compare the effects of four psychedelic compounds—psilocin (4 mg/kg), LSD (0.2 mg/kg), mescaline (100 mg/kg), and DOB (5 mg/kg)—on cortical EEG in freely moving rats. To maximise translational validity they recorded from a multichannel epidural array spanning frontal, sensorimotor and temporal/parietal cortices, analysed only epochs of behavioural inactivity as a resting‑state analogue, and quantified spectral power, topographic distributions and functional connectivity (cross‑spectral and phase‑lagged coherence) across four time windows before and after drug administration. The working hypothesis was that all substances would produce marked decreases in EEG power and connectivity.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Study Details

References (20)

Papers cited by this study that are also in Blossom

Psychometric evaluation of the altered states of consciousness rating scale (OAV)

Studerus, E., Gamma, A., Vollenweider, F. X. · PLOS ONE (2010)

The hallucinogenic world of tryptamines: an updated review

Araújo, A. M., Carvalho, F. M., Carvalho, M. et al. · Archives of Toxicology (2015)

Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

Halberstadt, A. L. · Behavioural Brain Research (2014)

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

Vollenweider, F. X., Kometer, M. · Nature Reviews Neuroscience (2010)

Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles

Tracy, D., Baumeister, D., Barnes, G. et al. · Therapeutic Advances in Psychopharmacology (2014)

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)

1174 cited
The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)

Decreased brain modularity after psilocybin therapy for depression

Daws, R. E., Timmermann, C., Giribaldi, B. et al. · Research Square (2021)

Show all 20 references
Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives

Pallavicini, C., Vilas, M. G., Villarreal, M. et al. · NeuroImage (2019)

51 cited
Neural correlates of the DMT experience assessed with multivariate EEG

Timmermann, C., Roseman, L., Schartner, M. et al. · Scientific Reports (2019)

Acute Biphasic Effects of Ayahuasca

Schenberg, E. E., Alexandre, J. F. M., Filev, R. et al. · PLOS ONE (2015)

101 cited
Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers

Riba, J., Anderer, P., Morte, A. et al. · British Journal of Clinical Pharmacology (2002)

Broadband Cortical Desynchronization Underlies the Human Psychedelic State

Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J. et al. · Journal of Neuroscience (2013)

427 cited
Sex differences and serotonergic mechanisms in the behavioural effects of psilocin

Tylš, F., Páleníček, T., Kadeřábek, L. et al. · Behavioural Pharmacology (2016)

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

Rickli, A., Moning, O. D., Hoener, M. C. et al. · European Neuropsychopharmacology (2016)

Neural correlates of the LSD experience revealed by multimodal neuroimaging

Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)

Cited By (1)

Papers in Blossom that reference this study

Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective

Dursun, S. M., Kelly, J. R., Gillan, C. M. et al. · Frontiers in Psychiatry (2021)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.